CytoMed Therapeutics
GDTC
$2.10
Share price
-2.33%
Change (1 day)
-37.31%
Change (1 year)
Categories
Revenue for CytoMed Therapeutics (GDTC)
Revenue in 2022: N/A
In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for CytoMed Therapeutics from 2020 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 | N/A | |
| 2021 | N/A | |
| 2020 | N/A |